{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:22:20Z","timestamp":1783563740346,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["TP-9346"],"award-info":[{"award-number":["TP-9346"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["2461"],"award-info":[{"award-number":["2461"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.micpath.2025.107566","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T03:21:31Z","timestamp":1744255291000},"page":"107566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Robust immune responses to intranasal vaccine targeting Bordetella pertussis antigens to claudin-4 on mucosal microfold cells"],"prefix":"10.1016","volume":"204","author":[{"given":"Negar","family":"Souod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-415X","authenticated-orcid":false,"given":"Fariborz","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5114-4173","authenticated-orcid":false,"given":"Farhad","family":"Riazi-rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-8246","authenticated-orcid":false,"given":"Saeed Reza","family":"Pakzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajihe Sadat","family":"Nikbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-2523","authenticated-orcid":false,"given":"Soheila","family":"Ajdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.micpath.2025.107566_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107566_bib2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107566_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000647","article-title":"Estimating the duration of pertussis immunity using epidemiological signatures","volume":"5","author":"Wearing","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2025.107566_bib4","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107566_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.micpath.2025.107566_bib6","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1080\/21645515.2018.1480298","article-title":"Prevention of pertussis: an unresolved problem","volume":"14","author":"Esposito","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107566_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/iai.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.micpath.2025.107566_bib8","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/iai.65.12.4904-4908.1997","article-title":"Role of gamma interferon in natural clearance of Bordetella pertussis infection","volume":"65","author":"Barbic","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2025.107566_bib9","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3389\/fimmu.2018.03068","article-title":"The role of mucosal immunity in pertussis","volume":"9","author":"Solans","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107566_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41385-021-00407-5","article-title":"IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils","volume":"14","author":"Borkner","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2025.107566_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.meegid.2016.02.032","article-title":"Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence","volume":"40","author":"Sealey","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2025.107566_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701285","article-title":"Mucosal immunization against pertussis: lessons from the past and perspectives","volume":"12","author":"Dubois","year":"2021","journal-title":"Front. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.micpath.2025.107566_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0264-410X(02)00516-9","article-title":"Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant","volume":"21","author":"Isaka","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107566_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/421486","article-title":"Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection","volume":"2014","author":"Olivera","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.micpath.2025.107566_bib15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107566_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mi.2012.54","article-title":"Immunity to the respiratory pathogen Bordetella pertussis","volume":"5","author":"Higgs","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"20","key":"10.1016\/j.micpath.2025.107566_bib17","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1016\/j.biomaterials.2010.03.047","article-title":"Mucosal vaccination using claudin-4-targeting","volume":"31","author":"Kakutani","year":"2010","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.micpath.2025.107566_bib18","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.3390\/ijms24065494","article-title":"Claudin-4: a new molecular target for epithelial cancer therapy","volume":"24","author":"Fujiwara-Tani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107566_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.micpath.2025.107566_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126352","article-title":"C-terminal Clostridium perfringens enterotoxin-mediated antigen delivery for nasal pneumococcal vaccine","volume":"10","author":"Suzuki","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2025.107566_bib21","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1038\/s41598-023-31198-3","article-title":"Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist RiboxximTM elicits strong antibody and T-cell responses in mice","volume":"13","author":"Horvath","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107566_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6750-12-7","article-title":"M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses","volume":"12","author":"Lo","year":"2012","journal-title":"BMC Biotechnol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107566_bib23","first-page":"753","article-title":"Subcutaneous administration of a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis induces mucosal and systemic immune responses","volume":"21","author":"Torkashvand","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"16","key":"10.1016\/j.micpath.2025.107566_bib24","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1080\/07391102.2020.1794966","article-title":"Computational evaluation of a fusion protein consisted of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis to target Claudin-4 using C-terminal fragment of Clostridium perfringens enterotoxin","volume":"39","author":"Souod","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.micpath.2025.107566_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/vaccines8040621","article-title":"Next-generation pertussis vaccines based on the induction of protective T cells in the respiratory tract","volume":"8","author":"Chasaide","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2025.107566_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1126107","article-title":"Generating enhanced mucosal immunity against Bordetella pertussis: current challenges and new directions","volume":"14","author":"Caulfield","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107566_bib27","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/IAI.69.8.4846-4850.2001","article-title":"Immunoglobulin A-mediated protection against Bordetella pertussis infection","volume":"69","author":"Hellwig","year":"2001","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.micpath.2025.107566_bib28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.186.11.1843","article-title":"Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes","volume":"186","author":"Mahon","year":"1997","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.micpath.2025.107566_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4049\/jimmunol.1602051","article-title":"Lung CD4 tissue-resident memory T cells mediate adaptive immunity induced by previous infection of mice with Bordetella pertussis","volume":"199","author":"Wilk","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107566_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/22221751.2018.1564630","article-title":"Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis","volume":"8","author":"Wilk","year":"2019","journal-title":"Emerg. Microb. Infect."},{"issue":"6","key":"10.1016\/j.micpath.2025.107566_bib31","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","article-title":"IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine","volume":"11","author":"Solans","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107566_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41541-020-00270-8","article-title":"Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage","volume":"6","author":"Dubois","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"3","key":"10.1016\/j.micpath.2025.107566_bib33","doi-asserted-by":"crossref","first-page":"e00607","DOI":"10.1128\/IAI.00607-20","article-title":"Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice","volume":"89","author":"Wolf","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2025.107566_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2018.03.012","article-title":"Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant","volume":"198","author":"Shi","year":"2018","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.micpath.2025.107566_bib35","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107566_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/AAC.40.4.1041","article-title":"Susceptibilities of Bordetella pertussis strains to antimicrobial peptides","volume":"40","author":"Fernandez","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107566_bib37","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3389\/fmicb.2018.02047","article-title":"Expanding the current knowledge about the role of interleukin-10 to major concerning bacteria","volume":"9","author":"Pe\u00f1aloza","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107566_bib38","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.171.6.3119","article-title":"Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology","volume":"171","author":"Higgins","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107566_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4049\/jimmunol.0803045","article-title":"IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response","volume":"184","author":"Wolfe","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.107566_bib40","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.3389\/fimmu.2018.02320","article-title":"Development of adjuvant-free bivalent food poisoning vaccine by augmenting the antigenicity of Clostridium perfringens enterotoxin","volume":"9","author":"Suzuki","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025002918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025002918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:14:16Z","timestamp":1769202856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025002918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"alternative-id":["S0882401025002918"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107566","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust immune responses to intranasal vaccine targeting Bordetella pertussis antigens to claudin-4 on mucosal microfold cells","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107566"}}